This site may not be displayed properly in the browser being used.
We recommend that you update to the latest browser.

It has been added to the cart.

It has been added to the comparison table.

Detail Information
  1. Top
  2. Life Science
  3. Physiology Research
  4. Active Pharmaceutical Ingredients (APIs)
  5. Endocrine / Metabolic Disorder (for Research Use)
  6. Risedronate Sodium Salt n-Hydrate

Risedronate Sodium Salt n-Hydrate

for Pharmacology Research
Specification Assay :
97.0+%(HPLC)
Manufacturer :
FUJIFILM Wako Pure Chemical Corporation
Storage Condition :
Keep at -20 degrees C.
CAS RN® :
115436-72-1
Molecular Formula :
C7H10NNaO7P2・nH2O
Molecular Weight :
(C7H10NNaO7P2=305.09)
GHS :
  • Close
  • Close
    Close
  • Structural Formula
  • Label
  • Packing
SDS
Comparison
Product Number
Package Size
Price
Availability
Certificate of Analysis
Purchase
Distributor
189-02461
Barcode No
4987481493094
100mg
List Price
218.00 USD

In stock in Japan
Distributor
Distributor
185-02463
Barcode No
4987481493100
500mg
Discontinued
Distributor

※Check  availability  in the US with the distributor.

Document

SDS
Product Specification Sheet
Spectral Data
Certificate of Analysis
Calibration Certificate

Application

Overview / Applications

Outline This product is for research use only. Do not administer it to human.

Osteoclastic Inhibitors: Research for Bone Metabolism

  • Risedronate Sodium Salt n-Hydrate (Wako Cat. #189-02461; #185-02463)

  • Alendronate Sodium Salt Trihydrate (Wako Cat. #012-22661; #018-22663)

Bone tissue is being remodeled by continuous deossification and ossification. The number of patients with osteoporosis caused by imbalance in the bone metabolism is increasing with the transition to an aging society.
This product is a bisphosphonate compound that is selectively distributed in the calcified bone surface to which the osteoclasts are attached. It is released under an acid environment created by the osteoclasts, taken in the cells, and inhibits the bone resorption activity. The inhibition of the bone resorption is considered to be caused by apoptosis induction effect of the osteoclasts and direct suppression of bone resorption of the osteoclasts.

Related Product:
TRAP/ALP Stain Kit (Wako Cat. #294-67001) - for enzyme activity staining of tartrate-resistant acid phosphatase -

Property

Appearance White - slightly yellow, crystals - powder

Manufacturer Information

Alias

  • Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-, monosodium salt

Same CAS list

For research use or further manufacturing use only. Not for use in diagnostic procedures.

Product content may differ from the actual image due to minor specification changes etc.

If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.

Ask for help